Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: teremoto, good point...Mark
3
Mar 14, 2011 10:38AM
3
Mar 14, 2011 10:50AM
2
Mar 14, 2011 12:28PM
6
Mar 14, 2011 12:42PM
12
Mar 14, 2011 01:05PM
2
Mar 14, 2011 02:23PM
4
Mar 14, 2011 02:35PM

This IMO qualifies as a redundant post. You made the proposition, responses where received closing the issue (one response from a knowledgeable attorney), and here we have it again.

Perhaps it is because of what you see as an outstanding issue? The qualification that the info has already been made public?

If the info is already in the public domain, why would the company be compelled to regergitate?

So they can take heat from shareholders saying "now tell us something we didn't already know"?

And if this a "hypothetical", why is this not being addressed on the OT forum?

HLs or Agora please take appropriate action, perhaps moving the message and this reply to the OT forum.

TIA,

SGE1

1
Mar 14, 2011 06:14PM
3
Mar 17, 2011 04:58PM
Share
New Message
Please login to post a reply